... of tumor cells and induces internalization of the receptor, thereby reducing the level of surface expression. This leads to inhibition of cell cycle progression and renders cancer cells more ... breast cancer patients. The PDGFR and its ligand, platelet-derived growth factor (PDGF), are overexpressed in many glioblastomas and in subsets of melanoma, ovarian, pancreatic, gastric, lung, and ... human cancer, and provide a mechanism to identify subsets of patients likely to respond to the targeted therapy. The wild-type EGFR is expressed by many other human cancers, and in colon cancer...